Agenus (AGEN) Interest Coverage Ratio: History & Chart

Agenus Inc.(AGEN)

Biotechnology · Lexington, MA

$7.91-0.83 (-9.45%)

Delayed quote: Oct 6, 2026, 1:05 PM EDT

About Agenus Inc.

Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes Retrocyte Display, a sophisticated antibody expression platform designed to identify fully human and humanized monoclonal antibodies, alongside other proprietary display technologies. Agenus is also actively involved in vaccine development programs, featuring the Prophage vaccine candidate and QS-21 Stimulon, a widely recognized saponin-based vaccine adjuvant. Its robust and diverse pipeline of therapeutic candidates targets various immune checkpoints and cancer pathways. Notable assets in clinical development include: Balstilimab: An anti-PD-1 antagonist that has successfully completed Phase II trials for the treatment of second-line cervical cancer. AGEN1181: A monospecific anti-CTLA-4 antibody currently undergoing Phase 1/2 clinical evaluation. AGEN2373: An anti-CD137 monospecific antibody in Phase 1 clinical trials. AGEN1423: A bi-functional anti-CD73/TGFß TRAP antibody, engineered to modulate the tumor microenvironment, which has concluded Phase 1 studies. AGEN1777: An anti-TIGIT bispecific antibody. AGEN1327: A human monoclonal antibody. INCAGN1876: An anti-GITR monospecific antibody. INCAGN1949: An anti-OX40 monospecific antibody. INCAGN2390: An anti-TIM-3 monospecific antibody. INCAGN2385: An anti-LAG-3 monospecific antibody. MK-4830: A monospecific antibody engineered to target ILT4. AGENT 797: An iNKT cell therapy, currently in Phase 1 for solid tumors, multiple myeloma, and viral ARDS, with ongoing clinical investigation for hematological malignancies and multiple myeloma/B cell indications. AGEN1884: A first-generation anti-CTLA-4 monospecific antibody. Agenus Inc. utilizes a portfolio of trademarks, including ASV, AutoSynVax, EVAMPLIX, MiNK, PSV, PhosPhoSynVax, Prophage, Retrocyte Display, and Stimulon, alongside its own company name. Strategic alliances are maintained with partners such as Incyte Corporation, Merck Sharpe & Dohme, Recepta Biopharma SA, and Gilead Sciences, Inc. Established in 1994, the company originally operated as Antigenics Inc. before rebranding to Agenus Inc. in January 2011. Its corporate headquarters are situated in Lexington, Massachusetts.

Lexington, MA

81 employees

www.agenusbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Garo H. Armen

View full financials

AGEN Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-0.37x

INTEREST COVERAGE RATIO AVG TTM

0.21x

INTEREST COVERAGE RATIO AVG 3Y

-0.75x

INTEREST COVERAGE RATIO AVG 5Y

-1.59x

INTEREST COVERAGE RATIO AVG 10Y

-2.54x

INTEREST COVERAGE RATIO AVG 15Y

-3.00x

INTEREST COVERAGE RATIO AVG 20Y

-3.78x

CURRENT VS TTM AVG

-274.22%

CURRENT VS 3Y AVG

+50.48%

CURRENT VS 5Y AVG

+76.74%

CURRENT VS 10Y AVG

+85.41%

CURRENT VS 15Y AVG

+87.67%

CURRENT VS 20Y AVG

+90.20%

SECTOR MEDIAN · HEALTHCARE

-5.79x

median of 488 covered companies

CURRENT VS SECTOR MEDIAN

+93.61%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Agenus Inc. (AGEN)	$329.18M	-0.37x	0.21x	-0.75x	-1.59x
CapsoVision, Inc. (CV)vs ›	$324.02M	N/A	N/A	N/A	N/A
ClearPoint Neuro, Inc. (CLPT)vs ›	$323.89M	-10.12x	N/A	N/A	N/A
Cabaletta Bio, Inc. (CABA)vs ›	$323.78M	-85.95x	N/A	N/A	N/A
Avita Medical Inc. (RCEL)vs ›	$322.13M	-8.50x	39.51x	19.80x	13.45x
Sanara MedTech Inc. (SMTI)vs ›	$321.57M	1.35x	1.35x	1.35x	1.35x
C4 Therapeutics, Inc. (CCCC)vs ›	$315.67M	N/A	N/A	N/A	N/A
Relmada Therapeutics, Inc. (RLMD)vs ›	$349.28M	N/A	N/A	N/A	N/A
Orchestra BioMed Holdings, Inc. (OBIO)vs ›	$349.70M	-45.13x	N/A	N/A	N/A
Mobia Medical, Inc. Common Stock (MOBI)vs ›	$305.56M	-47.93x	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Agenus Inc. (AGEN)

$329.18M

-0.37x

0.21x

-0.75x

-1.59x

CapsoVision, Inc. (CV)vs ›

$324.02M

N/A

ClearPoint Neuro, Inc. (CLPT)vs ›

$323.89M

-10.12x

N/A

Cabaletta Bio, Inc. (CABA)vs ›

$323.78M

-85.95x

N/A

Avita Medical Inc. (RCEL)vs ›

$322.13M

-8.50x

39.51x

19.80x

13.45x

Sanara MedTech Inc. (SMTI)vs ›

$321.57M

1.35x

C4 Therapeutics, Inc. (CCCC)vs ›

$315.67M

N/A

Relmada Therapeutics, Inc. (RLMD)vs ›

$349.28M

N/A

Orchestra BioMed Holdings, Inc. (OBIO)vs ›

$349.70M

-45.13x

N/A

Mobia Medical, Inc. Common Stock (MOBI)vs ›

$305.56M

-47.93x

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Agenus Inc. (AGEN)?

The interest coverage ratio for AGEN stock is -0.37x.

Is Agenus Inc.'s interest coverage ratio high or low?

The interest coverage ratio of -0.37x is 77% above its 5-year average of -1.59x, near the low end of its 5-year range (-3.98x–11.31x).

What is the TTM average interest coverage ratio for Agenus Inc. (AGEN)?

The TTM average interest coverage ratio for AGEN stock is 0.21x.

What is the 3Y average interest coverage ratio for Agenus Inc. (AGEN)?

The 3Y average interest coverage ratio for AGEN stock is -0.75x.

What is the 5Y average interest coverage ratio for Agenus Inc. (AGEN)?

The 5Y average interest coverage ratio for AGEN stock is -1.59x.

What is the 10Y average interest coverage ratio for Agenus Inc. (AGEN)?

The 10Y average interest coverage ratio for AGEN stock is -2.54x.

What is the 15Y average interest coverage ratio for Agenus Inc. (AGEN)?

The 15Y average interest coverage ratio for AGEN stock is -3.00x.

What is the 20Y average interest coverage ratio for Agenus Inc. (AGEN)?

The 20Y average interest coverage ratio for AGEN stock is -3.78x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	0.74x
2026-03-31	1.02x
2025-12-31	0.90x
2025-09-30	-0.35x
2025-06-30	-1.26x
2025-03-31	-1.04x
2024-12-31	-1.25x
2024-09-30	-0.88x
2024-06-30	-0.95x
2024-03-31	-1.12x
2023-12-31	-0.10x
2023-09-30	-2.49x
2023-06-30	-2.95x
2023-03-31	-3.28x
2022-12-31	-3.33x
2022-09-30	-2.67x
2022-06-30	-3.25x
2022-03-31	-2.33x
2021-12-31	-3.26x
2021-09-30	11.31x
2021-06-30	-3.98x
2021-03-31	-2.60x
2020-12-31	-1.34x
2020-09-30	-2.15x
2020-06-30	-2.27x
2020-03-31	-1.96x
2019-12-31	-1.63x
2019-09-30	-3.37x
2019-06-30	-4.20x
2019-03-31	2.87x
2018-12-31	-4.52x
2018-09-30	-3.46x
2018-06-30	-2.66x
2018-03-31	-15.01x
2017-12-31	-5.88x
2017-09-30	-6.73x
2017-06-30	-6.46x
2017-03-31	-2.89x
2016-12-31	-4.31x
2016-09-30	-8.21x
2016-06-30	-5.62x
2016-03-31	-6.77x
2015-12-31	-4.28x
2015-09-30	-7.90x
2015-06-30	-58.70x
2015-03-31	-46.09x
2014-12-31	-58.94x
2014-09-30	-24.74x
2014-06-30	-27.76x
2014-03-31	-27.61x
2013-12-31	-17.23x
2013-09-30	-19.64x
2013-06-30	-14.94x
2013-03-31	-3.75x
2012-12-31	-3.42x
2012-09-30	-3.81x
2012-06-30	-5.01x
2012-03-31	6.84x
2011-12-31	-4.39x
2011-09-30	-4.06x
2011-06-30	-4.47x
2011-03-31	-5.26x
2010-12-31	-4.20x
2010-09-30	-3.95x
2010-06-30	-3.83x
2010-03-31	-5.85x
2009-12-31	-4.30x
2009-09-30	-5.20x
2009-06-30	-5.67x
2009-03-31	-5.41x
2008-09-30	-7.56x
2008-06-30	-8.58x
2008-03-31	-7.99x
2007-12-31	-5.13x
2007-09-30	-7.81x
2007-06-30	-7.30x
2006-12-31	-10.28x
2006-09-30	-14.42x
2006-06-30	-18.74x
2006-03-31	-20.41x
2005-12-31	-22.98x
2005-06-30	-26.83x
2005-03-31	-29.13x
2004-12-31	-147.62x
2004-06-30	-123.66x
2004-03-31	-115.66x
2003-12-31	-124.33x
2003-09-30	-219.68x
2002-12-31	-1512.50x
2002-09-30	-242.26x

DATE

INTEREST COVERAGE RATIO

2026-06-30

0.74x

2026-03-31

1.02x

2025-12-31

0.90x

2025-09-30

-0.35x

2025-06-30

-1.26x

2025-03-31

-1.04x

2024-12-31

-1.25x

2024-09-30

-0.88x

2024-06-30

-0.95x

2024-03-31

-1.12x

2023-12-31

-0.10x

2023-09-30

-2.49x

2023-06-30

-2.95x

2023-03-31

-3.28x

2022-12-31

-3.33x

2022-09-30

-2.67x

2022-06-30

-3.25x

2022-03-31

-2.33x

2021-12-31

-3.26x

2021-09-30

11.31x

2021-06-30

-3.98x

2021-03-31

-2.60x

2020-12-31

-1.34x

2020-09-30

-2.15x

2020-06-30

-2.27x

2020-03-31

-1.96x

2019-12-31

-1.63x

2019-09-30

-3.37x

2019-06-30

-4.20x

2019-03-31

2.87x

2018-12-31

-4.52x

2018-09-30

-3.46x

2018-06-30

-2.66x

2018-03-31

-15.01x

2017-12-31

-5.88x

2017-09-30

-6.73x

2017-06-30

-6.46x

2017-03-31

-2.89x

2016-12-31

-4.31x

2016-09-30

-8.21x

2016-06-30

-5.62x

2016-03-31

-6.77x

2015-12-31

-4.28x

2015-09-30

-7.90x

2015-06-30

-58.70x

2015-03-31

-46.09x

2014-12-31

-58.94x

2014-09-30

-24.74x

2014-06-30

-27.76x

2014-03-31

-27.61x

2013-12-31

-17.23x

2013-09-30

-19.64x

2013-06-30

-14.94x

2013-03-31

-3.75x

2012-12-31

-3.42x

2012-09-30

-3.81x

2012-06-30

-5.01x

2012-03-31

6.84x

2011-12-31

-4.39x

2011-09-30

-4.06x

2011-06-30

-4.47x

2011-03-31

-5.26x

2010-12-31

-4.20x

2010-09-30

-3.95x

2010-06-30

-3.83x

2010-03-31

-5.85x

2009-12-31

-4.30x

2009-09-30

-5.20x

2009-06-30

-5.67x

2009-03-31

-5.41x

2008-09-30

-7.56x

2008-06-30

-8.58x

2008-03-31

-7.99x

2007-12-31

-5.13x

2007-09-30

-7.81x

2007-06-30

-7.30x

2006-12-31

-10.28x

2006-09-30

-14.42x

2006-06-30

-18.74x

2006-03-31

-20.41x

2005-12-31

-22.98x

2005-06-30

-26.83x

2005-03-31

-29.13x

2004-12-31

-147.62x

2004-06-30

-123.66x

2004-03-31

-115.66x

2003-12-31

-124.33x

2003-09-30

-219.68x

2002-12-31

-1512.50x

2002-09-30

-242.26x

Interest Coverage Ratio: -0.37x

AGEN Interest Coverage Ratio

AGEN Average Interest Coverage Ratio Chart

AGEN Current vs Average Interest Coverage Ratio Chart

AGEN Interest Coverage Ratio Metrics

AGEN Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

AGEN Interest Coverage Ratio History

Related Metrics